European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) is a non-profit, leading European professional organization, which focuses on advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care.
At ESMO, the ultimate goal is to eradicate cancer and advance cancer care, assuring that patients receive the high-quality care they deserve. To achieve this goal, ESMO constantly strives to address the issues that affect both its members and the oncology profession as a whole.
The myESMO community is a powerful alliance of committed oncology professionals. ESMO tailors its programs to meet its members’ professional development needs. They provide platforms for their members to continue to build up their expertise and to remain up-to-date with the competence and skills required to be recognized as top-quality oncology practitioners. Through ESMO awards, they recognize their members’ achievements in the field of oncology.
ESMO's sense of community reaches beyond medical oncology and across all oncology specialties. While the majority of ESMO's 6,000 members are medical oncologists, ESMO membership span over 100 countries and also includes radiation and surgical oncologists, as well as other oncology healthcare professionals actively involved in cancer treatment, research, and patient care.
Public Policy and Partnership
o European Union: ESMO is an authoritative voice in the fight against cancer and prepares position papers as well as offers consultative expertise to oncology organizations and European authorities on important issues related to cancer research, prevention, diagnosis, treatment and cure.
o Oncology partners: ESMO addresses the universal needs in oncology by being a reliable partner to all stakeholders in the multidisciplinary oncology environment. They know that they cannot fight this battle alone therefore through their activities they unite key oncology stakeholders who share common objectives. Enhancing relationships with European and national oncology societies, as well as cooperative research groups, consolidates and strengthens the European network and reinforces united efforts.
ESMO has been a member of the UICC since April 1997.